COR

As of August 8, 2026, Cencora, Inc. has a market capitalization of $62.3 billion, making it a large-cap company in the Healthcare sector.

Of the 46 analyst ratings on Cencora, Inc., 72% are Buy or Strong Buy, 12 are Hold, and 1 are Sell. The overall consensus rating is Buy. Analyst ratings are opinions, not investment advice.

The average analyst price target for Cencora, Inc. is $362.83. Individual targets range from $331.00 to $430.00.

Cencora, Inc. is scheduled to report earnings on November 4, 2026. Analysts expect earnings of $4.54 per share.

Yes — Cencora, Inc. has paid $2.35 per share in dividends over the trailing twelve months.

COR has a beta of 0.58, meaning it has historically been less volatile than the broader market.

Cencora, Inc. operates in the Healthcare sector, the Medical - Distribution industry, and its stock trades on NYSE.